Insulin Resistance : New Developments / John Freeman and Scott Newman, editors.

Saved in:
Bibliographic Details
Online Access: Full Text (via ProQuest)
Other Authors: Freeman, John, Newman, Scott
Format: eBook
Language:English
Published: New York : Nova Science, ©2013.
Series:Endocrinology research and clinical developments.
Subjects:
Table of Contents:
  • INSULIN RESISTANCE ; INSULIN RESISTANCE ; CONTENTS ; PREFACE ; PATHOPHYSIOLOGICAL BASISFOR ANTIOXIDANT THERAPY OF INSULIN RESISTANCE ; ABSTRACT ; INTRODUCTION ; PATHOPHYSIOLOGY OF INSULIN RESISTANCE ; Insulin-Resistance: Mechanisms of Disease ; Glucose Toxicity in IR; IR and Oxidative Stress Cross-Talking ; Polyol Pathway; Glucosamine Pathway; Kinase C Protein Activation ; TNF-alpha Activate JNK ; Advanced Glycation End Products and Oxidative Stress (AGEs) ; ANTIOXIDANT THERAPY IN INSULIN-RESISTANCE ; Resveratrol ; Antioxidant Effect of Resveratrol in Hepatoprotection.
  • Antioxidant Effect of Resveratrol in Pancreatic Protection Anti-Obesity Effects ; Anti-Diabetic Effects ; Antioxidant Vitamins ; Flavonoids ; Other Antioxidants ; CONCLUSION AND PERSPECTIVES ; REFERENCES ; NEW INSIGHT INTO THE REGULATION OF INSULIN RESISTANCE ; ABSTRACT ; 1. INTRODUCTION ; 2. THE EFFECT OF ENDOCRINE HORMONES ON INSULIN RESISTANCE ; 2.1. Galanin and Insulin Resistance ; 2.2. Ghrelin and Insulin Resistance ; 2. 3. Leptin and Insulin Resistance ; 2.4. Adiponectin and Insulin Resistance ; 2.5. RBP4 and Insulin Resistance.
  • 3. THE ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN REGULATING INSULIN RESISTANCE 4. THE GASTROINTESTINAL TRACT MICROBIOTA IN THE DEVELOPMENT OF INSULIN RESISTANCE ; 5. PPARS AND INSULIN RESISTANCE ; 6. VITAMIN D DEFICIENCY IN THE DEVELOPMENT OF INSULIN RESISTANCE ; 7. CURRENT GUIDELINES ON RISK FACTORS FOR INSULIN RESISTANCE, DIRECT AND INDIRECT INSULIN RESISTANCE ASSESSMENT METHODS ; 7.1. CRP; 7.2. Hyperinsulinemic Euglycemic Glucose Clamp ; 7.3. Oral Glucose Tolerance Test; 7. 4. HOMA- Insulin Resistance (IR) ; 8. THE NEW INSIGHT INTO PRIMARY PREVENTION AND THERAPY OF INSULIN RESISTANCE.
  • 8.1. SGLT2 8.2. MicroRNAs ; CONCLUSION ; REFERENCES ; INSULIN RESISTANCE AFTER SEVERE BURN INJURY ; ABSTRACT ; ABBREVIATIONS ; INTRODUCTION ; MATERIALS AND METHODS ; RESULTS ; Blood Glucose Levels before and after EIC ; PET Study of Glucose Uptake, Oxygen Extraction Fraction and Blood Flow in Hind Limb Skeletal Muscle ; Changes in Endogenous Glucose Production After EIC ; DISCUSSION ; ACKNOWLEDGMENTS ; REFERENCES ; LIPOPROTEIN LIPASE AND INSULIN RESISTANCE ; ABSTRACT ; INTRODUCTION ; BACKGROUND OF LIPOPROTEIN LIPASE (LPL) ; RELATIONSHIP BETWEEN LPL AND LIPID METABOLISM AND ATHEROSCLEROSIS.
  • EFFECT OF LPL ACTIVATOR NO-1886 ON LPL, LIPID METABOLISM AND ATHEROSCLEROSIS EFFECT OF LPL ACTIVATOR NO-1886 ON FATTY LIVER ; RELATIONSHIP BETWEEN LPL AND OBESITY AND INSULIN RESISTANCE ; REFERENCES ; INDEX.